Genaissance Pharmaceuticals Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 11 pages Genaissance Pharmaceuticals, Inc. Restricted Stock Agreement Granted Under 2000 Amended and Restated Equity Incentive Plan
12/34/56
EX-10.6
from PREM14A 2 pages Clinical Data, Inc. 2005 Equity Incentive Plan Article 1. Background and Purpose of the Plan Article 2. Share Limits
12/34/56
EX-10.4
from PREM14A 2 pages Clinical Data, Inc. 1991 Stock Option Plan
12/34/56
EX-10.3
from PREM14A 2 pages Clinical Data, Inc. 1991 Directors’ Stock Option Plan
12/34/56
EX-10.7
from 8-K 26 pages Security Agreement
12/34/56
EX-10.6
from 8-K 13 pages Pledge and Security Agreement
12/34/56
EX-10.5
from 8-K 22 pages Security Agreement
12/34/56
EX-10.4
from 8-K 17 pages Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 15 pages Warrant No. to Purchase Common Stock of Genaissance Pharmaceuticals, Inc
12/34/56
EX-10.2
from 8-K 4 pages Senior Secured Note
12/34/56
EX-10.1
from 8-K 47 pages Note and Warrant Purchase Agreement Among Genaissance Pharmaceuticals, Inc., Lark Technologies, Inc., the Co-Borrowers, and Xmark Opportunity Fund, L.P., Xmark Opportunity Fund, Ltd., and Xmark Jv Investment Partners, LLC, the Purchasers Dated: April 21, 2005 Note and Warrant Purchase Agreement
12/34/56
EX-10.68
from 10-K/A ~20 pages Material contract
12/34/56
EX-10.67
from 10-K/A ~50 pages Material contract
12/34/56
EX-10.66
from 10-K/A ~20 pages Material contract
12/34/56
EX-10.64
from 10-K/A 1 page Material contract
12/34/56
EX-10.65
from 10-K 1 page Material contract
12/34/56
EX-10.63
from 10-K ~5 pages Material contract
12/34/56
EX-10.62
from 10-K 1 page Material contract
12/34/56
EX-10.61
from 10-K 1 page Material contract
12/34/56
EX-10.60
from 10-K ~5 pages Material contract
12/34/56